Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential

Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease, is a clinically heterogeneous disorder, with obscure etiology and no disease-modifying therapy to date. Currently, there is no available biomarker for PD endophenotypes or disease progression. Accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelopoulou, Efthalia, Paudel, Yam Nath, Villa, Chiara, Piperi, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601048/
https://www.ncbi.nlm.nih.gov/pubmed/33036336
http://dx.doi.org/10.3390/brainsci10100713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601048/
https://www.ncbi.nlm.nih.gov/pubmed/33036336
http://dx.doi.org/10.3390/brainsci10100713

Ejemplares similares